Ohio Attorney General Mike DeWine has extended an agreement that allows state and local agencies that purchase the opioid antidote drug naloxone to receive rebates.
The drug’s manufacturer, Amphastar Pharmaceuticals, says the company will provide a $6 rebate for each naloxone syringe purchased by a nonfederal public entity between March 2, 2018, and March 31, 2019.
So far, the rebate has saved 127 agencies a total of $732,384 for naloxone purchases made between March 2015 and December 2017.
When given to a person overdosing on heroin or a prescription opioid, naloxone can limit or stop the overdose by reversing the effects of the opioid on the brain.
Public entities that qualify for the rebates include, but are not limited to, law enforcement agencies, the Ohio Department of Mental Health and Addiction Services, Project DAWN (Deaths Avoided with Naloxone) community programs, and county and local governments.
Public entities interested in applying for the Naloxone rebate should visit
www.OhioAttorneyGeneral.gov/NaloxoneRebate.